Novanta Inc.
corporate_fare Company Profile
Novanta Inc. (NASDAQ:NOVT) is a publicly traded company in the Manufacturing sector. Wiseek has independently scored 17 items for NOVT at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-09, rated 7/10. Across its 17 most recent items scored 7 or higher, the top rating is 9/10, with 10 rated 8 or above. Recent SEC coverage for NOVT spans 10-Q, 8-K, 8-K/A, 144.
Recent high-impact activity:
- Novanta 10-Q: Q3 Revenue Up 23% to $305M, GAAP EPS $0.05, Debt Jumps to $829.8M
- Novanta Q3 Revenue Up 23% to $305M; Q4 EPS Guidance Flat at 0-5% Growth
- Novanta Posts 3Q Adjusted EPS of $1.05
- Novanta Discloses Riverpoint Medical Financials: $1.45B Deal, $250M Milestone Due January 2027
- Novanta Q2 Revenue Climbs 10.3% to $265.8M; Riverpoint Medical Acquisition Closes
Financial Snapshot
Short Interest & Short Volume
14.83 days to coverFINRA reported short interest of 5,248,696 shares in NOVT as of the October 30, 2026 settlement, a 0.2% increase from the prior period — about 14.8 days to cover at its recent average daily volume. On November 20, 2026, 52.2% of NOVT volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
Low riskFiling-implied dilution signals for NOVT, detected from its recent SEC filings · based on capital-structure filings through 2026-06-09.
Private Placement Priced · Significant Discount to Market Price
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →